Diebold Nixdorf (DBD) Reports In-Line Q4 Revenue
Get Alerts DBD Hot Sheet
Price: $68.67 +0.70%
Financial Fact:
Net income attributable to noncontrolling interests: 800K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Net income attributable to noncontrolling interests: 800K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q4 EPS of $3.02, may not compare to the analyst estimate of $1.34. Revenue for the quarter came in at $1.04 billion versus the consensus estimate of $1.03 billion.
Full-year 2024 Outlook
- RevenueLow single-digit growth
- Adjusted EBITDA 1$410M - $435M
=
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share